CELLDEX THERAPEUTICS, Inc. (CLDX) Misses Q3 EPS by 1c

CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) reported Q3 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $2.01 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Celldex to Present at Upcoming Investor Conference
• Signet shares jump on Q2 profit beat, raised annual guidance
• Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance